Aim: Transcutaneous bone conduction devices such Sophono™, help to overcome the problems with the skin of percutaneous bone conduction hearing aid devices such as BAHA connect™ (Revisional surgery, infection/granulation, implant covered by skin).To assess the outcomes and clinical safety of the Sophono Alpha 2MPO™ in a series of patients with conductive, mixed and neurosensorial hearing losses, we conducted this study.Conclusion: in our experience with Sophono™ implant device, the outcomes and clinical safety are satisfactory and supports it's the reliable use, for patients with conductive, mixed and sensorineural hearing losses.A special attention would be taken with patients with sensorineural hearing losses respect to their adherence to device and counseling should be emphasized in this regard in the preoperative period.